Sonnet BioTherapeutics Holdings, Inc. BURG Balance Sheet

Sonnet biotherapeutics holdings, inc. (BURG)

Balance Sheet / Yearly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Dec'10
ASSETS
Current assets:
Cash
548	500	637	579	561	523	1,091	1,485	411	272	295	377	277	268	990	983	-	1,224	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	165	-	-	-
Restricted cash
0	0	0	0	0	0	6	27	102	165	250	275	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts and other receivables, net
63	131	-	-	-	325	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,178	-	1,805	2,808	3,324	245	322	273	476	442	213	160	389	1,223	1,694	3,568	229	-	223	1	46
Restricted cash
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3,000	2,750	-	-	-	-	-	-	-	-	-
Accounts and other receivables, net
-	-	223	518	523	-	365	641	344	475	275	330	349	524	222	830	956	862	194	413	309	313	386	118	173	227	156	134	72	161	119	78	55	108	66	41	4
Other receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	44	45	49	50	159	70	78	85	118	96	-	42	-	-	-
Other receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	58	-	-	-	0
Inventories
271	287	354	421	424	335	407	345	388	460	463	560	520	539	517	499	646	569	593	591	607	532	542	475	432	381	198	169	178	227	180	140	145	105	-	-	0
Due from related parties
-	-	-	-	-	-	-	-	-	-	-	-	-	-	45	45	45	-	45	45	45	46	108	113	113	116	116	113	113	117	149	110	77	76	75	106	84
Prepaid expenses and other current assets
933	249	342	249	192	159	316	701	247	324	333	367	424	461	346	377	480	568	421	517	463	330	510	552	570	495	-	-	-	-	-	-	-	-	-	-	-
Assets held for sale, net
-	-	-	-	-	-	0	2,090	2,090	100	725	578	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	436	216	216	170	300	102	173	144	99	76	24
Assets held for sale, net
-	-	1,901	-	-	-	-	-	-	-	-	-	-	-	0	1,673	-	593	-	-	-	-	-	-	-	-	51	55	89	44	-	-	-	-	-	-	-
TOTAL CURRENT ASSETS
1,817	1,169	3,460	1,769	1,703	1,343	2,187	5,291	3,584	1,799	2,344	2,489	1,571	1,793	2,123	4,409	3,307	3,818	3,061	4,376	4,750	1,468	1,914	1,578	1,815	1,713	4,331	3,670	1,139	2,030	2,563	4,096	739	641	464	226	158
Property and equipment, net
5,325	5,630	8,159	9,012	10,156	9,756	9,532	8,236	8,203	8,548	9,006	10,342	11,498	11,513	11,531	11,599	16,409	12,144	17,855	14,572	14,993	13,315	14,591	12,697	8,522	5,620	5,047	2,127	2,226	2,316	2,422	2,042	1,745	1,505	17	20	25
Operating lease assets
11,256	11,668	14,524	17,712	18,662	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Goodwill
8,513	8,567	10,498	11,274	11,312	10,564	11,334	10,126	10,164	12,647	12,603	12,540	12,438	12,405	12,518	12,569	12,701	12,702	12,269	15,812	15,445	15,617	18,191	9,182	9,168	6,496	2,053	396	396	396	-	-	-	396	-	-	0
Intangible assets, net
3,565	3,656	4,479	4,887	5,002	4,469	5,462	5,600	5,759	5,896	6,310	6,374	6,441	6,530	6,571	6,635	7,204	6,776	7,542	6,024	6,096	3,396	3,751	3,608	3,408	3,424	2,398	624	629	559	933	968	972	325	-	-	0
Investments
389	381	373	-	-	800	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Investments
-	-	-	365	800	-	800	800	800	800	800	800	800	800	11	11	29	800	35	35	35	35	-	-	-	55	-	-	-	-	-	-	-	-	105	425	-
Investments at fair value
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	35	35	-	-	-	-	-	-	-	-	-	-	-	-	-
Investments at fair value
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	43	-	12	19	33	56	54	80	212	318	-	-	352
Other investments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,050	1,050	1,050	-	1,550	1,550	1,550	1,550	1,550	1,550	2,551	2,491	1,970	1,983	2,102	2,116	2,148	1,804	1,700	1,582	-	-	853
Investments accounted for under the equity method
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	786	92	-
Investments accounted for under the cost method
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	766	766	-
Deposits and other assets
302	309	350	401	447	386	449	452	452	490	499	509	465	442	314	297	685	574	297	401	486	408	463	517	246	285	213	166	165	169	130	100	59	29	23	23	23
Assets of discontinued operations
149	149	-	-	-	2,472	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Assets of discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	5,389	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
TOTAL ASSETS
31,319	31,532	41,847	45,423	48,086	29,793	29,766	30,507	28,965	30,183	31,564	33,056	33,215	33,486	34,120	36,573	41,387	42,205	42,610	42,772	43,357	35,791	40,499	29,169	25,756	20,087	16,028	8,989	6,693	7,646	8,252	9,093	5,430	4,798	2,165	1,555	1,414
LIABILITIES, REDEEMABLE SHARES, AND STOCKHOLDERS' DEFICIT
Current liabilities:
Line of credit and notes payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	625	574	234	-	238	7	-	1,171	-	-	-
Derivative liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,341	-	-	-	-	-	-	-	-	-	-
Accounts payable and accrued expenses
7,847	8,165	7,431	9,527	8,266	6,176	7,110	6,503	6,305	5,797	5,384	5,040	5,265	5,553	4,669	5,401	6,447	4,740	4,420	6,868	6,424	5,580	5,368	3,572	2,704	2,423	1,550	-	-	1,108	-	-	735	-	-	-	277
Current maturities of long-term debt and notes payable
6,348	6,630	6,682	6,619	6,772	3,663	6,333	6,157	5,957	5,741	771	928	784	6,171	6,130	6,188	-3,130	5,383	1,134	3,195	997	1,813	2,092	1,959	1,474	835	-	-	-	236	-	-	1,185	-	1,301	-	250
Current maturities of convertible notes payable
-	-	-	-	3,000	3,000	3,000	3,000	3,000	3,000	-	-	-	0	3,604	3,450	3,130	2,810	215	268	196	436	363	289	216	0	-	-	-	-	-	-	2,725	1,625	-	-	0
Current operating lease liabilities
3,183	3,299	3,240	3,594	3,750	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Advances from investors
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	575	2,750	-	-	-	-	-	-	-	-	-
Accounts payable and accrued expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,102	1,069	-	821	922	-	478	-	-	-
Accounts payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	191	296	-
Accrued expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	13	9	-
Other current liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	105	102	235	361	360	352	370	330	-	-	1
Current maturities of capital leases payable
-	-	-	-	-	-	-	-	-	-	4	9	14	18	22	25	33	39	47	55	54	42	85	58	58	59	47	30	32	27	36	39	-	41	-	-	-
Deferred rent
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	132	111	109	-	19	20	15	10	8	5	-	43	-	-	-
Loan payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	951	1,571	-	-	-	-	-	-	-	-	-	-	-	-	-
Notes payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	247	-
Deferred revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-
Due to related parties
-	-	-	137	185	185	191	191	191	191	194	194	194	194	209	209	597	12	212	616	818	1,299	186	12	12	12	12	13	13	13	13	27	30	30	44	84	116
Current maturities of capital leases payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	38	-	-	-	0
Deferred rent
-	-	-	-	-	-	-	-	-	-	89	106	100	-	95	117	739	683	686	609	320	118	-	-	-	53	-	-	-	-	-	-	3	-	-	-	0
Derivative Liability
826	-	-	-	-	-	-	-	-	-	-	-	-	-	0	102	615	1,231	1,318	1,847	2,080	1,945	1,513	1,734	2,006	2,146	-	-	-	0	-	-	-	-	-	-	-
Liabilities held for sale, net
-	-	1,645	-	-	-	-	-	-	-	-	-	-	-	161	1,832	-	1,279	-	-	-	-	-	-	-	-	9	9	21	14	-	-	-	-	-	-	-
TOTAL CURRENT LIABILITIES
18,205	18,095	19,000	19,879	21,975	13,025	16,635	15,852	15,454	14,731	6,444	6,280	6,359	11,937	14,892	17,329	17,776	16,181	8,212	13,664	11,119	11,412	10,693	9,310	6,583	5,531	5,287	4,602	1,623	1,772	1,478	1,355	5,087	3,720	1,550	638	645
Other liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	100	108	121	186	201	216	234	263	-	-	0
Long-term debt
-	-	-	-	-	3,000	-	-	-	-	5,142	4,533	6,013	287	305	303	0	1,098	5,419	2,867	5,654	5,009	5,016	180	196	398	-	-	-	0	0	231	233	236	238	-	686
Convertible notes payable, net of unamortized premium of $0 and $12,256, respectively
-	-	-	-	-	-	0	0	0	212	3,214	3,217	3,374	3,678	-	-	-	0	2,294	2,012	2,010	1,477	1,166	916	666	416	-	-	-	0	-	-	-	-	-	0	-
Redeemable preferred stock Series 1: no par value, 62,876 shares issued and outstanding, net of discount of $130,436 and $139,131, respectively
718	709	700	692	683	674	666	657	648	640	631	622	589	257	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Capital leases payable, less current maturities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	4	9	13	15	25	40	55	36	60	73	89	105	63	36	44	60	67	74	84	85	-	-	0
Convertible note payable, net of debt discount of $2,833,333
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	166	-	-	-	-	0	-	-	-	-	-
Deferred rent
-	-	-	-	-	2,297	2,102	2,037	2,107	2,156	2,006	2,207	2,051	2,135	2,037	2,048	1,523	1,740	1,784	1,955	2,206	2,196	1,857	1,852	1,837	1,055	1,204	99	99	98	89	76	62	7	-	-	0
Long-term operating lease liabilities
14,064	14,382	15,909	16,800	17,228	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue
935	959	983	-	-	1,174	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred tax liabilities
102	102	-	-	-	76	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Liabilities of discontinued operations
247	435	-	-	-	1,287	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue
-	-	-	1,007	1,115	-	1,195	1,215	1,236	175	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	25	48	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Liabilities of discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	124	58	177	177	179	177	-	-	-	1	-	-	-	-	-	-	-	-	-	-	-
Deferred tax liabilities
-	-	119	119	119	-	0	206	443	779	1,591	1,559	1,485	1,485	1,450	1,421	1,386	1,353	655	618	652	686	1,242	1,275	1,313	1,340	-	-	-	0	-	-	-	-	-	-	-
TOTAL LIABILITIES
34,273	34,684	36,714	38,499	41,122	21,535	20,598	19,969	19,890	18,694	19,030	18,419	19,873	19,781	18,690	21,112	21,018	20,448	18,392	21,158	21,699	20,819	20,037	13,608	10,687	8,848	6,822	4,846	1,888	2,117	1,837	1,953	5,701	4,312	1,788	638	1,332
Commitments and contingencies (see Note 11)
-	-	-	-	-	-	0	0	-	-	0	-	-	0	-	-	-	0	-	-	-	0	0	0	0	0	0	-	0	0	0	0	0	0	0	-	0
Convertible Preferred Stock: Series 2: $1,000 stated value; authorized 1,500 shares; 787 issued and outstanding
459	-	-	-	-	-	-	-	-	-	0	0	349	349	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stockholders' Deficit:
Preferred stock: no par value; authorized 5,000,000 shares; 62,876 issued and outstanding
-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Common stock: $0.0001 par value; authorized 45,000,000 shares; issued and outstanding 549,336 and 400,167 shares, respectively
1	1	1	0	0	0	0	0	0	0	0	0	2	0	2	2	2	2	2	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Common stock warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	16	-
Additional paid in capital
-	-	71,222	71,210	65,126	64,756	63,217	63,208	61,263	60,750	59,506	59,996	57,099	55,926	56,264	55,739	55,365	55,365	-	-	-	-	32,615	31,159	30,634	-	21,501	14,992	14,947	14,898	14,849	15,327	6,483	6,459	6,436	6,302	5,456
Common stock subscribed, unissued
-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Subscriptions receivable
-	-	-	2,694	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Additional paid in capital
73,470	71,505	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	55,208	46,040	42,983	32,601	-	-	-	25,404	-	-	-	-	-	-	-	-	-	-	-
Other comprehensive income (loss)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	146	-30	-64	-	-155	-163	-191	-181	-167	-188	-63	50	-156	15	68
Accumulated deficit
-77,343	-75,068	-66,183	-62,270	-59,025	-57,124	-54,831	-53,565	-52,776	-49,109	-46,942	-45,357	-43,957	-42,206	-40,284	-39,627	-34,438	-33,012	-30,607	-26,123	-23,144	-20,876	-17,885	-17,334	-15,923	-14,472	-12,126	-10,703	-9,996	-9,258	-8,379	-7,639	-6,795	-6,092	-5,425	-4,929	-4,929
Accumulated other comprehensive loss
-127	-46	-391	-232	-164	-202	-140	-106	-109	-934	-934	-966	-1,108	-1,155	-1,247	-1,162	-791	-987	-911	-3,122	-2,943	-1,657	-	-	-	-88	-	-	-	-	-	-	-	-	-	-	-
Less treasury stock, 256,615 shares at December 31, 2011
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	526	526	526	526	536	536
Total Sonnet BioTherapeutics Holdings, Inc., Stockholders' Equity
-3,998	-3,607	4,647	6,014	5,936	7,430	8,245	9,536	8,377	10,706	11,629	13,673	12,035	12,564	-	-	-	21,367	-	-	-	-	-	15,560	15,068	-	9,205	4,142	4,805	5,528	6,415	7,140	-271	485	376	917	82
Non-Controlling Interests
584	455	485	909	1,026	827	921	1,001	698	782	904	964	958	791	696	510	231	389	-527	4,818	4,762	4,904	5,584	1,764	421	394	-13	17	45	70	112	165	631	593	48	48	24
TOTAL STOCKHOLDERS' DEFICIT
-3,414	-3,152	5,132	6,923	6,963	8,257	9,167	10,537	9,075	11,488	12,534	14,637	12,993	13,355	15,430	15,461	20,369	21,757	24,218	21,614	21,658	14,972	20,461	-	-	11,238	-	-	-	-	-	-	-	-	-	-	-
TOTAL LIABILITIES, REDEEMABLE SHARES, AND STOCKHOLDERS' DEFICIT
31,319	31,532	41,847	45,423	48,086	29,793	29,766	30,507	28,965	30,183	31,564	33,056	33,215	33,486	34,120	36,573	41,387	42,205	42,610	42,772	43,357	35,791	40,499	29,169	25,756	20,087	16,028	8,989	6,693	7,646	8,252	9,093	5,430	4,798	2,165	1,555	1,414